Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says By: MarketWatch June 20, 2023 at 03:23 AM EDT The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to keep up with demand. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says By: MarketWatch June 20, 2023 at 03:23 AM EDT The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to keep up with demand. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR